Application Note
CHOZN® ZFN-Modified CHO Cell Lines For Bioproduction
The foundation for biopharmaceutical companies to develop a platform production process, thus enabling regulatory acceptance and commercial consistency, is a robust cell line that maintains favorable growth and productivity characteristics.
SAFC® has created a series of zinc finger nuclease (ZFN) modified CHO cell lines with characteristics that are attractive in a platform cell line to biopharmaceutical developers and manufacturers. These characteristics include selecting the cells for their capacity to exhibit.
The content you requested is only available to registered users of Bioresearch Online. By registering now, you'll get exclusive access to this piece of content and thousands of addtional articles and product reviews across our entire network of sites.
